Gynesonics is at the forefront of developing innovative technologies aimed at enhancing women's health, particularly in the treatment of symptomatic uterine fibroids. Their flagship product is the world’s first and only intrauterine fibroid ablation system, which uniquely integrates ultrasound guidance with targeted radiofrequency energy. This advanced system allows for a transcervical, incisionless procedure, ensuring a safer and more effective treatment option for patients suffering from fibroids.

The combination of ultrasound and radiofrequency energy not only enhances the precision of the ablation process but also minimizes the risks typically associated with surgical interventions. By focusing on patient safety and comfort, Gynesonics aims to provide a transformative solution that addresses the needs of women dealing with fibroid-related symptoms. Their commitment to advancing medical technology underscores their mission to improve women's lives through innovative healthcare solutions.

United States

Gynesonics is a medical technology company that specializes in providing minimally invasive solutions for women's health, particularly in the treatment of uterine fibroids.

Gynesonics

Company Details